Insurtech companies can leverage data in this way to make the process more efficient for both the insurer and the insured.
Featured Article
Rounds that matter: Fintech’s fortunes, DAO dreams, Asia’s reseller revival
Here are the venture rounds and other startup-related financial news from the past week that you need to know about.
A lot has happened with SVB, and unless it’s your job to edit the news, it’s possible you missed a slice of the saga, if not the entire story. Here’s…
3 investors presage the future of startups and VC following SVB’s downfall
“There’s going to be an extreme shift in general in the financial industry when it comes to financing startups.”
With the end of 2022 right around the corner, here’s a look at some of the more interesting answers some of our surveys unearthed this year.
For now, it seems as though designers will stick with Figma for lack of a reasonable alternative, which is something that Adobe and Figma can build on.
Hear us out. It’s conventional wisdom that meetings are killers of productivity and morale and happy work environments. So why not write an email?
Coinbase is having to defend its model to investors who may have bought into its stock when it was trading much higher. And per its own notes, the bad times…
TechCrunch+ roundup: Revisit your marketing stack, pitch deck teardown, after the acquisition
Marketing can’t cure everything that ails a company, but it is the easiest channel to make iterative changes that produce immediate results.
TechCrunch+ roundup: SBA startup loans, quarterly board decks, bootstrappers’ delight
There’s one bright light amidst the gloom: Startups that generate enough revenue to drive steady growth will find many investors willing to take their calls.
TechCrunch+ roundup: Pricing strategy, technical due diligence, pitch deck appendix fever
Unlike soft drinks, startups are not a volume business, which means they must revisit their pricing models regularly.
TechCrunch+ roundup: SaaS success stats, leveraging ad tech chaos, 2022 layoff trends
I remember the dread I felt as a startup worker during downturns when I read about mass layoffs at tech firms that had previously been considered ascendant.
TechCrunch+ roundup: CEO pregnancy checklist, decision-tree planning, reassessing valuations
It sounds counterintuitive, but in this environment, a lower valuation might help you retain and hire talented employees.
TechCrunch+ roundup: Non-dilutive biotech capital, long-term angel investing, WayRay’s $80M pitch deck
As a veteran startup worker who has been laid off during economic downturns, it’s dissonant to hear investors say this is a good time to launch a software startup. They’re…
TechCrunch+ roundup: Food tech smorgasbord, VCs squeeze crypto founders, startup layoffs 101
According to The Good Food Institute, fermentation startups received $290 million of the $911 million investors dropped on alternative protein companies in Q1 2022.
TechCrunch+ roundup: Climate tech survey, AI/ML marketing strategy, immigration law Twitter Space
It’s difficult to build high-growth clean tech companies using venture capital. Despoiling the planet has a much higher return on investment than saving it.
TechCrunch+ roundup: 11 PLG tactics, addressing copycat stigma, ‘unicorn glut’ theory
Tech’s rolling green meadows are seeing fewer new unicorns, but the slowing venture market suggests that past mega-deals are making it harder for early-stage startups to fundraise.
TechCrunch+ roundup: Optimizing dev teams, O-1A visa criteria, growth’s golden metric
If you’ve ghosted someone after extending a verbal offer of employment, that’s going to be a consideration for future candidates. People talk!
TechCrunch+ roundup: Stripe vs. Plaid, IP litigation, what VCs really think about the downturn
If you work in a startup, here’s some real talk: Your managers are not giving you the full picture of your company’s financial situation.
TechCrunch+ roundup: Construction tech survey, founder-CEO friction, diversify your cap table
As you may have heard, tech companies are having a bit of a whoopsie.
TechCrunch+ roundup: DTC data strategy, starting up solo, insuretech growth versus risk
Fundraising is only one part of the journey. If you can’t connect with an investor who’ll help you find and fill in your gaps with regard to talent or expertise,…
TechCrunch+ roundup: Find your valuation, international visas, hiring for growth
If your face doesn’t appear on the team slide in your company’s pitch deck, this would be a good time to cancel your upcoming vacation. And maybe one of your…
TechCrunch+ roundup: Drive growth with Q5 data, BNPL investor survey, calculating CAC/LTV
Round sizes are getting smaller, but investors are raising their expectations: how fluent are you when it comes to your startup’s key metrics?
TechCrunch+ roundup: Psychedelic investor survey, 6 issues VCs look for, hiring on a budget
If you can envision a solution that solves a customer’s problem, it helps to have technical skills if you want to bring it to market. But that’s not a requirement.
TechCrunch+ roundup: Immigration law Q&A, finding your problem, why a16z pitched Deel
This week, we’re running several articles on entrepreneurship as TechCrunch staffers recap their conversations and panel discussions from our Early Stage event earlier this month. Stay tuned!
TechCrunch+ roundup: VC ‘bottom feeders,’ valuation calculator, think like an investor
Farmers don’t get embarrassed when the price of corn drops; similarly, there’s no reason for startup founders to lose their joy because publicly traded tech stocks are undercutting their valuations.
TechCrunch+ roundup: Musk’s Twitter bid, European cannabis survey, borrowing against NFTs
The U.S. is the world’s largest cannabis market, but as more European countries consider legalizing recreational use, investors are looking for opportunities in production, distribution and retail.
TechCrunch+ roundup: The Kindbody TC-1, Glossier’s mistakes, calculating startup runway
With a focus on education that addresses the fragmentation associated with infertility care, Kindbody is growing at a remarkable pace, but it’s also helping many patients feel seen and heard…
It’s telling of our maturity as a society that infertility is a concept approached with awkwardness and uncertainty.
TechCrunch+ roundup: Psychedelic biotech, Gogoro’s SPAC, H-1Bs for Ukrainians
You may not have heard of Amadeus, but if you’ve taken a trip, you’ve probably interacted with its tech stack.